International journal of obesity (2005)

Stigma linked to GLP-1 receptor agonist treatments: a call for clearer understanding

Updated

Abstract

GLP-1 medications may be associated with a new form of weight stigma that goes beyond body size.

  • Moral narratives around weight management often emphasize discipline and personal responsibility, framing GLP-1-assisted weight loss as a 'shortcut.'
  • These perceptions reflect broader societal attitudes that stigmatize weight management approaches that utilize medications.
  • GLP-1-related stigma encompasses judgments about the legitimacy and moral worthiness of using pharmacologic treatments for weight loss.
  • This compounded stigma could lead to increased negative health impacts and hinder engagement with GLP-1 treatments.
  • Investigating the differences between weight-based stigma and GLP-1-related stigma may enhance understanding and support for individuals with obesity.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free